John G. Cox

2015

In 2015, John G. Cox earned a total compensation of $5M as EVP, Pharmaceutical Operations and Technology at Biogen, a 12% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$144,138
Non-Equity Incentive Plan$258,348
Salary$674,753
Stock Awards$3,559,612
Other$340,997
Total$4,977,848

Cox received $3.6M in stock awards, accounting for 72% of the total pay in 2015.

Cox also received $144.1K of change in pension value and nonqualified deferred compensation earnings, $258.3K in non-equity incentive plan, $674.8K in salary and $341K in other compensation.

Rankings

In 2015, John G. Cox's compensation ranked 1,604th out of 13,638 executives tracked by ExecPay. In other words, Cox earned more than 88.2% of executives.

ClassificationRankingPercentile
All
1,604
out of 13,638
88th
Division
Manufacturing
579
out of 5,187
89th
Major group
Chemicals And Allied Products
214
out of 1,857
89th
Industry group
Drugs
165
out of 1,531
89th
Industry
Biological Products, Except Diagnostic Substances
27
out of 260
90th
Source: SEC filing on April 15, 2016.

Cox's colleagues

We found six more compensation records of executives who worked with John G. Cox at Biogen in 2015.

2015

George Scangos

Biogen

Chief Executive Officer

2015

Douglas Williams

Biogen

Former EVP, Research and Development

2015

Stuart Kingsley

Biogen

Former EVP, Global Operations

2015

Susan Alexander

Biogen

Chief Legal Officer

2015

Kenneth DiPietro

Biogen

EVP, Human Resources

2015

Paul Clancy

Biogen

Chief Financial Officer

You may also like